Trustees’ Annual Report for the period
From 01.01.2024 Period start date To 31.12.2024 Period end date Charity name: UK Acute Oncology Society
Charity registration number: 1199351
Objectives and Activities
| SORP reference | ||
|---|---|---|
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | •For the public benefit, to advance the education of all healthcare professionals involved in treating or supporting patients in the field of acute oncology. •In furtherance of the object above, to promote research for the public benefit in all aspects of that subject and to publish the useful results. •The relief of sickness and preservation of health, from cancer, among people residing permanently or temporarily in the UK. •To assist in the treatment and care of persons suffering from cancer, or in need of rehabilitation, by the provision of education for healthcare professionals. •To promote the wellbeing of people suffering from acute effects of cancer and/or anti-cancer treatment and support the development of acute oncology services in the UK through assisting in the provision of education. |
| Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts. |
Para 1.17 and 1.19 |
1. Provision of forum for Health Care professionals supporting emergency cancer care. 2. Annual educational programme. 3. Website and educational resources. 4. Supporting service innovation, shared learning and research promotion. |
| Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit |
Para 1.18 | The UKAOS trustees have had regard to the guidance issued by the Charity Commission on public benefit. |
Additional information (optional) You may choose to include further statements where relevant about:
SORP reference
Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other
Achievements and Performance
| SORP reference | ||
|---|---|---|
| Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole. |
Para 1.20 | Ongoing UKAOS Governance Review The UKAOS initiated a Trustee rotation as per the constitution with 3 new Trustees appointed and 2 Trustee farewells. As part of a wider Governance review, a newly established Programme Management Group (Nov 23) conducted a review of UKAOS Subgroups with refreshed Terms of Reference and several significant changes in line with the evolving UKAOS priorities including: Closure of the trainee subgroup (in favour of integrating trainees across all groups). Closure of the Radiotherapy Toxicity subgroup (in favour of an amalgamated approach to Treatment Toxicity). Launch of 3 new Subgroups: Nursing, Malignancy of Unknown origin (MUO) and Metastatic Spinal Cord Compression (MSCC) – each recognising national leadership in these areas from UKAOS. UKAOS Influence Development and stakeholder engagement of the first UKAOS 5-year Strategy (2025- 2030) – subsequently published 2025. |
| UKAOS engagement with NHS England |
|---|
| successfully delivering Oncology as a core |
| component of national Same Day |
| Emergency Care (SDEC) Strategy. |
| 4 Nation Cancer Hotline Review – national |
| survey and analysis 2024. |
| Formal agreement for UKAOS clinical |
| representation at national bodies |
| (Association of Cancer Physicians, Royal |
| College of Radiologists). |
| First national Acute Oncology Week 7-11th |
| Oct 24. |
| UKAOS Board member awarded MBE. |
| Successful Launch of first ever Nepal Acute |
| Oncology Service Model with UKAOS |
| support. |
| UKAOS Education & Training |
| Successful delivery of a national 1-day |
| UKAOS Conference (Sept 24). |
| Co Chairmanship and launch of National |
| Acute Oncology Education Group. |
| Successful sessional delivery of UKAOS at |
| national conferences (UK Oncology Forum |
| June 24, UK SACT Board Nov 24), Society |
| of Acute Medicine AO Webinar Dec 24. |
| UKAOS agreement to deliver monthly online |
| learning hour through 2025. |
Additional information (optional) You may choose to include further statements where relevant about:
| Achievements against objectives set |
Para 1.41 | |
|---|---|---|
| Performance of fundraising activities against objectives set |
Para 1.41 | |
| Investment performance against objectives |
Para 1.41 |
Other
Financial Review
| Financial Review | ||
|---|---|---|
| Review of the charity’s financial position at the end of the period |
Para 1.21 | Details of receipts and payments are given in the Receipts and Payments Account within the financial statements. The total unrestricted funds as at 31 December 2024 amounted to £4,755 (2023: £20,074) |
| Statement explaining the policy for holding reserves stating why they are held |
Para 1.22 | To fund future projects. |
| Amount of reserves held | Para 1.22 | The free reserves at 31 December 2024 are £4,755 (2023: £14,074) and the trustees are satisfied that this level of reserves is sufficient to meet the needs of the charity in its early stages of development. |
| Reasons for holding zero reserves |
Para 1.22 | Not applicable. |
| Details of fund materially in deficit |
Para 1.24 | None. |
| Explanation of any uncertainties about the charity continuing as a going concern |
Para 1.23 | There are no uncertainties about the charity continuing as a going concern. |
Additional information (optional) You may choose to include further statements where relevant about:
| The charity’s principal sources of funds (including any fundraising) |
Para 1.47 | |
| Investment policy and objectives including any social investment policy adopted |
Para 1.46 | |
| A description of the principal risks facing the charity |
Para 1.46 | |
| Other |
Structure, Governance and Management
| Description of charity’s trusts: |
||
|---|---|---|
| Type of governing document (trust deed, royal charter) |
Para 1.25 | Constitution. |
| How is the charity constituted? (e.g unincorporated association, CIO) |
Para 1.25 | Charitable Incorporated Organisation (CIO) |
| Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees |
Para 1.25 | Election by UKAOS members at Annual General Meeting. |
Additional information (optional) You may choose to include further statements where relevant about:
Policies and procedures adopted for the induction Para 1.51 and training of trustees The charity’s organisational structure and any wider Para 1.51 network with which the charity works Relationship with any related Para 1.51 parties Other
Reference and Administrative details
| Charity name | UK Acute Oncology Society |
|---|---|
| Other name the charity uses | UKAOS |
| Registered charity number | 1199351 |
| Charity’s principal address | UKAOS Secretariat c/o Media1 Productions Ltd Clarence Mill, Clarence Road Bollington Macclesfield SK10 5JZ |
Names of the charity trustees who manage the charity
Trustee name Office (if any)
Dates acted if not for whole year
Name of person (or body) entitled to appoint trustee (if any)
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Dr E Marshall | Chair | ||
|---|---|---|---|---|
| Dr C Mitchell | Upto 1.9.24 | |||
| Dr H J Williams | Treasurer | |||
| P J Jones | ||||
| N R Clatworthy | Upto 1.9.24 | |||
| Dr C Wilson | Secretary | |||
| J Upton | From 1.9.24 | |||
| D Munro | From 1.9.24 | |||
| P Gillis | From 1.9.24 | |||
– Corporate trustees names of the directors at the date the report was approved
Director name
Name of trustees holding title to property belonging to the charity
Trustee name Dates acted if not for whole year
Funds held as custodian trustees on behalf of others
Description of the assets None. held in this capacity Name and objects of the Not applicable. charity on whose behalf the assets are held and how this falls within the custodian charity’s objects
Details of arrangements for Not applicable. safe custody and segregation of such assets from the charity’s own assets
Additional information (optional)
Names and addresses of advisers (Optional information)
Type of Name Address adviser
Name of chief executive or names of senior staff members (Optional information)
Exemptions from disclosure
Reason for non-disclosure of key personnel details Not applicable.
Other optional information
Not applicable
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
Signature(s) Full name(s) Dr ERNEST MARSHALL Position (eg Secretary, Chair, etc) Chair Date 24/10/2025
| UK Acute Oncology Society (UKAOS) Charity Name |
UK Acute Oncology Society (UKAOS) Charity Name |
UK Acute Oncology Society (UKAOS) Charity Name |
1199351 No (if any) |
1199351 No (if any) |
1199351 No (if any) |
CC16a | |
|---|---|---|---|---|---|---|---|
| For the period from |
01-Jan-24 Period start date |
To | 31-Dec-24 Period end date |
||||
| Section A Receipts and payments | |||||||
| A1 Receipts | Unrestricted funds to the nearest £ 14,000 - - - - - - - 14,000 4,800 - 4,800 18,800 265 848 21,306 900 10,800 - - - - 34,119 - - - 34,119 - 15,319 - 20,074 4,755 |
Restricted funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Endowment funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Total funds to the nearest £ 14,000 - - - - - - - 14,000 4,800 - 4,800 18,800 265 848 21,306 900 10,800 - - - - 34,119 - - - 34,119 - 15,319 |
Last year to the nearest £ |
||
| Sponsorships and grants | 14,000 | 20,000 | |||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| Sub total(Gross income for AR) |
14,000 | 20,000 | |||||
| Fundsreceivedinerror | 4,800 | 6,000 | |||||
| - | - | ||||||
| Sub total | 4,800 | 6,000 | |||||
| Total receipts A3 Payments |
|||||||
| 26,000 | |||||||
Bank charges |
265 | 300 | |||||
Website expenses |
848 | 2,058 | |||||
Secretariat |
21,306 | **7,162 ** | |||||
| Accountancy | 900 | 900 | |||||
| Repayment for funds received in error |
10,800 | - | |||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| **Sub total ** | 34,119 | 10,420 | |||||
| A4 Asset and investment purchases (see table) |
|||||||
| , | - | ||||||
| - | |||||||
| **Sub total ** | - | - | |||||
| Total payments Net of receipts/(payments) A5 Transfers between funds A6 Cash funds last year end Cash funds this year end |
|||||||
| 10,420 | |||||||
| - 15,319 | - | - | - 15,319 | 15,580 | |||
| - | - | - | - | - | |||
| 20,074 | - | - | 20,074 | 4,494 | |||
| 4,755 | - | - | 4,755 | 20,074 |
CCXX R1 accounts (SS)
20/10/2025
1
| Section B Statement of assets and liabilities at the end of the period | Section B Statement of assets and liabilities at the end of the period | Section B Statement of assets and liabilities at the end of the period | |
|---|---|---|---|
| Categories Signed by one or two trustees on behalf of all the trustees B1 Cash funds B2 Other monetary assets B4 Assets retained for the charity’s own use B5 Liabilities B3 Investment assets |
Signature Details Bank Details Total cash funds (agree balances with receipts and payments account(s)) Details Details Details |
Unrestricted funds Restricted funds to nearest £ to nearest £ 4,755 - - - - - 4,755 - OK OK Unrestricted funds Restricted funds to nearest £ to nearest £ - - - - - - - - - - - - Fund to which asset belongs Cost (optional) - - - - - Fund to which asset belongs Cost (optional) - - - - - - - - - Fund to which liability relates Amount due (optional) - - - - Print Name E MARSHALL |
Endowment funds to nearest £ |
| - | |||
| - | |||
| - | |||
| - | |||
| OK | |||
| Endowment funds to nearest £ |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Current value (optional) |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Current value (optional) |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| When due (optional) |
|||
| Date of approval |
|||
| E MARSHALL | 24/10/2025 | ||
CCXX R2 accounts (SS)
20/10/2025
2